2. 2
OVARCOME
Gala 2015
Saturday, May 16, 2015, 6:30 P.M.
Hotel Sorella, City Centre
PROGRAM
COCKTAILS AND SILENT AUCTION
MISTRESS OF CEREMONIES: Melinda Spaulding and Lisa Slater
BOARD ADDRESS: Mike Beck
Ovarcome Board Member & Chief Sales Officer & Head of Marketing, Direct Energy
WELCOME REMARKS: Dr. Ronald A. DePinho, M.D.
President, The University of Texas MD Anderson Cancer Center
PRESIDENT’S ADDRESS: Runsi Sen
PLEDGE DRIVE
KEYNOTE SPEECH & HONOREE: Dr. Robert C. Bast, Jr., M.D.
Vice President for Translational Research, The University of Texas MD Anderson Cancer Center
COMMUNITY SERVICE AWARD: Karen Shayne, Co-Founder, Women Survivors Alliance
GLOBAL IMPACT AWARD: Manisha Koirala
International Movie Actress & Cancer Crusader
RESEARCH GRANT AWARDS: Foundation For Women’s Cancer
LIVE AUCTION
DINNER
ENTERTAINMENT
Songs by: Chloe & Pamela Mary
Survivor Runway Walk: Ovar The Moon!
VOTE OF THANKS: Board Members
3. May 2015 3
Runsi Sen
Founder & President,
Ovarcome Non-profit Inc.
Join me in my mission to overcome ovarian cancer!
Since our inception in 2012, Ovarcome has made great strides with your blessing and support. I founded Ovarcome in my
mother’s memory – she lost her battle to ovarian cancer only a year after her diagnosis. Our mission at Ovarcome is to
raise global awareness, to fund research in search of a cure, and to provide financial support to underprivileged women
in the U.S. as well as developing nations in their valiant fight against ovarian cancer. Ovarcome is my purpose and passion
in life – my humble effort to keep her spirit alive through this foundation. We work with major national and international
hospitals and organizations to raise awareness on ovarian cancer, we award research grants to impact early detection,
novel treatments, and patient survival and we offer OvarCare, our financial support program for underprivileged women
diagnosed with ovarian cancer. Ovarcome’s resolve is to try to save lives of mothers, wives, daughters, sisters, and friends
– because every woman deserves a fighting chance!
1 in 71 women have the likelihood to develop ovarian cancer in their lifetime, regardless of age, race and background. This
year, 22,000 women will be diagnosed in the U.S. alone. There is no screening option. Symptoms are non-specific, which
result in only 25% of ovarian tumors being detected at a curable stage. However, when detected early, survival rate is 90%!
It is imperative to educate and empower women with information and awareness so that we can collectively work towards
increasing survival. It is a critical time for research, to find breakthroughs and to find a cure for ovarian cancer!
Ovarcome is now 3 – so far we have hosted several domestic and international workshops and grassroots campaigns to raise
awareness on ovarian cancer, we have awarded research grants to MD Anderson and Foundation of Women’s Cancer and have
financially supported more than 30 women nationally and internationally via our OvarCare program.
Despite our best efforts, thousands of women get diagnosed every year. Unfortunately, this reality is not going to change
overnight. Ovarcome is my tribute to every mother, daughter, sister, friend, wife and significant other that has been touched
by ovarian cancer or has lost their battle against it. Ovarcome is my dream of a world that is free from the scourge of cancer.
We are all in this together – cancer touches us all. We are just beginning to empower! “Miles to go before we sleep!”
Ovarcome is committed to saving lives of women around the world through education, awareness, empowerment, early
action, and treatment support for underprivileged.
We are here today because of you – thank you for being such incredible partners! Wishing you all a happy and healthy life!
Sincerely,
Runsi Sen
5. May 2015 5
When cancer strikes,
we strike back.
As a recognized leader in the fight against cancer, MDAnderson continues to pioneer new approaches
in cancer treatment. Using the latest genetics-based research, we can develop targeted treatments,
personalized to the individual patient. To learn more about how we are raising the bar for cancer care
worldwide, call toll free 1-855-894-0145 or visit MakingCancerHistory.com.
At MD Anderson Cancer Center, we are focused on Making Cancer History.®
Ranked one of the top two hospitals
for cancer care in the nation for 25
years by U.S. News &World Report.
6. May 2015 6
Our Services:
• Emergency Care
• Orthopedics
• Spine
• Women’s Services
• Diagnostic Imaging
• Surgical Services,
including Robotic
• Cardiovascular
• Neuroscience
• Neurosurgery
Better
health is
right around
the corner.
Sugar Land Hospital
1317 Lake Pointe Parkway
Sugar Land, TX 77478
281-637-7000
stlukessugarland.com
You don’t have to go far to get the top-quality medical and
surgical services you need to feel better and live better.
CHI St. Luke’s Health–Sugar Land Hospital is in the neighborhood
and offers a compassionate, healing environment with private
rooms for all patients. Families throughout Sugar Land trust
us for their medical care, and we are dedicated to helping
everyone in our community get healthy and stay healthy.
To learn more about our services and to experience a virtual
tour of our facilities, visit stlukessugarland.com.
7. May 2015 7
We all know the story – when the woman in a household
falls sick, the center of gravity shifts and imbalance strikes.
Women are not only creators, they are also optimizers
and balancers. Women bring grace, beauty, compassion,
love, unconditional support, resilience, and beauty to life.
Thousands of such beautiful women succumb to ovarian
cancer every year, all over the world. Ovarian cancer is the
deadliest of all gynecological cancers – over 239,000 new
cases will be diagnosed worldwide this year. About 58%
of ovarian cancer cases occur in less developed countries.
The fight against ovarian cancer is real – every woman is
at risk, and this cancer strikes regardless of age, race,
nationality or background. We helplessly lose mothers,
wives, daughters, friends, and partners despite the best
possible fight.
When detected early, survival rate is over 90%. However,
there is still no effective screening program in place for
ovarian cancer. Mammograms, pap smears and annual well
woman exams can’t screen for ovarian cancer. Despite
our best efforts, thousands of women get diagnosed every
year. It is absolutely critical to raise awareness and to
empower women to become ovarian cancer crusaders!
Ovarian cancer doesn’t get as much attention as breast
cancer, in spite of the grim statistics. Awareness is low
and symptoms are vague and non-specific. Our awareness
work has just begun – we want to educate women, their
families/partners, primary physicians and healthcare
professionals on the signs, symptoms and prevention
measures. Diet, lifestyle choices, exposure to chemicals,
stress, depression, lack of sleep can all contribute to the
progression of ovarian cancer – and awareness is a must
in combating this disease. Ovarcome is our humble effort
to raise much needed awareness on ovarian cancer –
think teal!
It is a critical time for research, to find a cure and
to win our battle against ovarian cancer. We need to
improve diagnosis and find novel treatments and targeted
therapies. Ovarcome is our humble effort to support
research in collaboration with our partner institutions
to fund outstanding research efforts.
We have made it our mission to support women battling
this disease while trying to pay bills, run a family, support
their children, and make ends meet while going through
the biggest challenge of their lives. Our sincere hope is
to be able to hold a hand and help a survivor by easing
her financial and emotional burden so she could focus on
herself. Health precedes wealth, education, success or
relationships. Ovarcome is our humble effort to support
such women who fight this disease everyday gracefully
and resiliently.
Join Our Cause And Help Us Ovarcome!
Message From The Board
9. May 2015 9
Our work globally is currently focused on awareness campaigns and providing treatment support to
underprivileged women in developing nations.
IN INDIA:
Financial Grants for Treatment Support: We provide these grants in India to underprivileged women for multiple
rounds of chemotherapy treatment in direct partnership with well-renowned hospitals. In India, underprivileged women
often subsist on less than $100 per month, and the cost of chemotherapy can range from $250 - $500, depending on the
round and stage of treatment. We have expanded our partnerships in India and very proud to announce that we are on
our way to become the exclusive sponsor of all ovarian cancer patients being treated at Tata Memorial Hospital, Mumbai
under the Women’s Cancer Initiative program!
Physician Led Detection, Prevention and Screening Workshops: We conduct physician led workshops regarding
women’s cancers (ovarian, breast and cervical) in rural areas of India and educate on early detection of symptoms,
prevention and screening techniques. We are also planning to host quarterly HPV vaccination camps to address the rising
incidence of cervical cancer in India.
Awareness Programs: We promote women’s cancer awareness by distributing informational postcards translated in
various regional languages of India and by organizing grassroots outreach campaigns with the help of local volunteers.
IN AFRICA:
Awareness Programs: We partnered with Christian Ministries of Africa (CMA) in 2013 and 2014 to distribute
awareness postcards to hundreds of women in and outside of Nairobi, Kenya. Our representatives and on-site
volunteers talked to women in these regions about the signs and symptoms of ovarian cancer and discussed
treatment options with them. Similar programs are being planned in Kenya and other parts of Africa in 2015.
What We Do Globally
10. May 2015 10
8
COMBATING CANCER
WITH EXPERTISE
memorialhermann.org
Your stand against cancer starts here.
Memorial Hermann Cancer Centers have received full accreditation by the
American College of Surgeons Commission on Cancer, making us Houston’s
first recognized Integrated Network Cancer Program. This approval means our
Cancer Centers meet national standards established to ensure cancer patients
receive high-quality care. Our eight accredited centers make cancer treatment
accessible and convenient to where you live or work. And our caring staff and
Oncology Nurse Navigators are with you every step of the way.
SEEING FUTURE CANCERTREATMENTS IN
DRUGSTHAT ALREADY EXIST.
THAT’S THE DIFFERENCE BETWEEN PRACTICING
MEDICINE AND LEADING IT.
At Houston Methodist, we’re shortening the path to a cure by researching new ways of getting there.
That’s why we’re exploring powerful compounds in existing drugs and repurposing them into new
treatments to fight cancer. By doing so, we’re not only giving drugs a new life, we’re also offering
patients new hope.
For an appointment with a Houston Methodist cancer specialist, visit houstonmethodist.org
or call 713.790.3333.
11. May 2015 11
Keynote Address
Dr. Bast is best known for developing the OC125 monoclonal antibody that led to the production of the CA125
radioimmunoassay. Serum CA125 levels have provided the first generally useful marker for monitoring the course
of patients with epithelial ovarian cancer. CA125 is currently being evaluated as one component of a screening
strategy for ovarian cancer. His early studies focused on the use of immunostimulants and monoclonal antibodies
for cancer therapy. Dr. Bast continues to care for patients with breast and ovarian cancer and has been listed in
the Best Doctors of America and in America’s Top Physicians.
Dr. Bast received his B.A. cum laude from Wesleyan University and his M.D. magna cum laude from Harvard
Medical School. After completing a medical internship at the Johns Hopkins Hospital, he served as a research
associate at the National Cancer Institute. Returning to Boston, Dr. Bast completed a medical residency at
the Peter Bent Brigham Hospital and a fellowship in Medical Oncology at the Dana-Farber Cancer Institute.
He joined the faculty at Harvard as an Assistant Professor and was subsequently appointed Associate Professor
at the Dana-Farber Cancer Institute. Dr. Bast was recruited to the Duke University Medical Center in 1984 as
Professor of Medicine, Microbiology and Immunology to Co-Direct the Division of Hematology-Oncology and to
serve as Clinical Director of the Cancer Center. In 1987, he became the Director of the Duke Comprehensive
Cancer Center and in 1992 he was named Welcome Clinical Professor of Medicine in Honor of R. Wayne Rundles.
In July 1994, Dr. Bast was recruited to head the Division of Medicine at UT M. D. Anderson Cancer Center and
to fill the Harry Carothers Wiess Chair for Cancer Research. In 2000, Dr. Bast was appointed Vice President for
Translational Research. In 2004, he became the Harry Carothers Wiess Distinguished University Professor for
Cancer Research.
ROBERT C. BAST, JR.
Vice President of Translational Research,
MD Anderson Cancer Center
12. May 2015 12
From 2008-2010, practicing healthcare administrator
and ovarian cancer survivor, Karen Shayne conducted
research as to what was needed specifically for
women survivors. With a healthcare background
AND the opportunity to sit on both sides of the desk
as an administrator and a survivor, Karen began to
ask those direct questions. Cancer research saved
lives, but then what? What happens when you are
unplugged from the last chemo treatment, given the
cupcake and sent home? What happens in those quiet
moments of a still house when you are faced with the
questions, “Who am I? What does that mean?” “Will I
ever feel ‘normal’ again?” in early 2012, Karen, with
her Co-Founder Judy Pearson officially joined forces,
stepped away from their careers, and combined their
life savings to create the Women Survivors Alliance, a
501c3 with a HUGE mission to create social change.
With a growing audience (and many curious eyes
upon them), Karen, Judy, the Board of Directors and
the National Advisory Board executed the official
“launch” of the Women Survivors Alliance at Gaylord
Opryland Resort in August 2013. SURVIVORville 2013
saw an attendance of 847 registrants, 112 cancer
organizations, all from 49 states and five countries.
During the launch, the WSA introduced NOU, the
nation’s only women survivors digital magazine. In
Spring of 2014, and as an expansion of the tradition
of My 2nd Act essays at SURVIVORville 2013, the
WSA launched My 2nd Act: Survivor Stories from the
Stage – a live stage show showcasing local women
survivors who have created a 2nd Act of life in their
survivorship.
KAREN SHAYNE:
OVARIAN SURVIVOR
Co-Founder: SURVIVORville,
Women Survivors Alliance
Manisha Koirala is an Indian actress, as well as a UNFPA
Goodwill Ambassador and social activist. Manisha is
not just a survivor. In her own words, she is a cancer
crusader and will grab every opportunity to raise
awareness about the disease. Manisha was born in the
Nepali Koirala family- her dad, B.P. Koirala, was Nepal’s
Prime Minister before her birth, while two of her
paternal grandfather’s brothers, Girja Prasad Koirala,
and M.P. Koirala were also Nepali Prime Ministers during
the 1990s.
Manisha has won five awards for her performance
in ‘Bombay’, ‘Khamoshi: The Musical’(two awards),
‘Company’, and ‘Escape from Taliban’. She has
obtained a Diploma in Film Making from New York,
U.S.A., and is a member of the Independent Film-
Makers Society. She is well versed in Indian classical
dance forms.
Manisha calls herself a “cancer crusader”. “A crusader
has the attitude which gives you strength, because
that is what you need when you are fighting a disease,
which may be cancer or some other thing.” “There
is a stigma that cancer means death. No, it is not so.
I know lot of people who got cancer, got treatment
and are fine. Let us crusade against any kind of
challenges,” Manisha says: “The disease has taught
me what all that is important in my life. I want to tell
people how fragile life is. We should value our life,
our health.”
Sources: OCRF, MD Anderson Cancer Center,
SURVIVORville, Times of India, Wikipedia,
MANISHA KOIRALA:
OVARIAN SURVIVOR
International Movie Actress/
Bollywood Star &
Cancer Crusader
13. May 2015 13
Being a caregiver to a cancer patient became my second full-time job when my wife of 34 years was diagnosed with
ovarian cancer in 2010. I’ve described it as the hardest job I’ve ever loved. It’s a job that began with some of the
toughest news anyone can ever hear: “your wife has cancer.”
Connie was the least likely person, in my opinion, to have cancer. She had always taken care of herself - avoided alcohol,
didn’t smoke, exercised, always had physicals and the proper tests, everything exactly the way it’s supposed to be done.
She just didn’t meet the profile for cancer, particularly not ovarian cancer. However, I quickly learned that cancer does
not discriminate; it preys on the ones we love despite their age, gender, or lifestyle.
At the moment of her diagnosis, our life was sent spiraling in an entirely different direction than planned. It’s like a car
wreck: it happens so fast, you’re here to there in seconds. With the diagnosis, your world changes in a moment. We went
from planning our retirement years to the survival mode.
I immersed myself in the details of the disease, but soon learned ovarian cancer is a formidable foe. It was like playing
chess blindfolded. We always anticipated the next move, but almost always too late. Connie lost her life to ovarian
cancer last September after a 4 ½ year battle and I tried to pick up the pieces of my life after being married for 38 to
this amazing person. At first, I didn’t want to hear the words “ovarian cancer” ever again. But I soon realized I could not
walk away from the ovarian cancer community, people I’ve met and love who share the same passion for early detection,
research, and a cure.
Ovarian cancer isn’t a woman’s issue; it’s a family issue. My years of caring for Connie were the most difficult and
rewarding of my life. My love and appreciation for caregivers only multiplied as I began to understand the commitment,
responsibility, and sacrifice required for caring for a loved one. That is why I appreciate and support Ovarcome. I love
the Mission of awareness and research, but especially the emphasis of supporting underprivileged women, families, and
caregivers in in the US and developing nations. Ovarcome allows me to continue be a caregiver through my financial
support, a job I still love.
Jack Allen:
Caregiving
Ovarcome Supporter &
Caregiver’s Advocate, Ovarian
Cancer National Alliance
14. May 2015 14
Dr. Jaydip Bhaumik DGO MS DNB FRCOG MPH
Senior Consultant
Gynaecological Oncology
Tata Medical Center
Neha is 21. A real all-rounder, she went to one of the
best schools in Kolkata, India and got admission into a
great university. Neha’s father Anish is an accountant
who works for a multinational company. Sarada is 58. A
widow for more than 10 years she built a ‘hair-cutting
salon’ in a small town at the outskirts of Kolkata using
all the savings her husband had left when he died.
Neha woke up in the early morning with quite severe
pain in her abdomen. She thought she must have had
overdone it in the gym last evening, so she took some
painkillers and tried to sleep. The pain, however, would
not subside so her parents took her to a local hospital.
Her abdomen was swollen, tense and tender. Neha was
found to have large tumours affecting both the ovaries.
There was plenty of fluid surrounding the tumours and
the tumour markers were raised. All these features
were highly suggestive of an ovarian malignancy. She
was shifted to the Tata Medical Center under my care.
Sarada had been suffering from problems of indigestion
for many years. Sarada endured her discomfort until it
became quite painful and she could hardly eat properly.
When the local doctor saw Sarada, she had a tense and
swollen abdomen full of fluid. The doctor drained the
fluid and when tested it showed cancer cells. She was
also sent to me about the same time when I saw Neha.
Both Neha and Sarada had ovarian cancer. Sarada was
sent to the medical oncology department to start
chemotherapy. Her son said “Doctor, my mother is
going to die anyway. What is the point in spending so
much money in treating her?” At Tata Medical Center
we are fortunate to have supporters and organizations
like Ovarcome who would help needy patients. I told
her son that we will try our best to arrange financial
support. Samir agreed and Sarada’s treatment started
with chemotherapy. While Neha was taken to the
operating theatre for surgery, Anish held my hand and
said, “Doctor, Neha must live. She is too young to die.”
The estimated cost of surgery for ovarian cancer in our
hospital is $3,000 - $4,000. The success of treatment
of ovarian cancer depends on several factors, most
importantly the stage. In India there are other factors
that influence survival.These are socio-economic status,
cultural beliefs and taboo and above all willingness to
undergo treatment.
I am very pleased that Ovarcome has come forward to help women in India who suffer from ovarian cancer.
Not only they would provide financial support to the needy women, they are planning to organise awareness
and education initiatives so that the Saradas in the country get equal opportunity to undergo treatment for
ovarian cancer.
FROM THE DOCTOR’S DESK:
OVARCOME’S WORK IN INDIA
15. May 2015 15
Founded in 2012, Ovarcome Non-Profit, Inc. is a global ovarian cancer foundation inspired by the simple philosophy
of support, love, and a celebration of life.
Our Dream:
A world that is free from the scourge of Cancer.
Our Vision:
To be the leading global non-profit organization helping women overcome ovarian cancer and celebrate life!
Our Mission:
To raise global awareness, to fund research in search of cures, and to provide financial support to underprivileged
women in their valiant fight against ovarian cancer.
Ovarcome Non-Profit Inc. is a IRS 501(c)3 tax-exempt ovarian cancer
organization, based out of Houston, Texas, USA.
Ovarcome: A Journey Of Hope And Hearts
18. May 2015 18
Ovarian Cancer: What You Need to Know
In 2012, the American Cancer Society estimated that 22,280 women would be diagnosed with ovarian cancer in the United
States and 15,500 women will die from the disease making ovarian cancer the leading cause of death from gynecologic
cancers in the United States and the 5th leading cause of cancer death among American women. Approximately 50% of
women diagnosed with ovarian cancer will be alive within five years of their diagnosis. When diagnosed early, the five-
year survival is greater than 92%. However, only one fifth of ovarian cancer is found before it has spread outside the
ovaries. Approximately 60% of women with ovarian are diagnosed with advanced stage (Stage III or IV) disease, when the
cancer cells have spread to tissues outside the pelvis or regional lymph nodes.
The cause of the majority of cases of ovarian cancer is unknown. However, there are certain factors that may increase
the risk of ovarian cancer including family history of breast, uterine, colon or rectal cancer, strong family history of
ovarian or breast cancer, personal history of cancer or endometriosis, age greater than 55, women who have never been
pregnant, and women who take estrogen by itself for greater than 10 years. Inherited mutations in the BRCA1 and BRCA2
genes account for 10% of all epithelial ovarian cancers. These mutations are often found in families with a strong history
of ovarian or breast cancer. According to the National Cancer Institute, women in the general population have a 1.4 % (14
out of 1000) lifetime risk of getting ovarian cancer compared to a 15-40% lifetime risk of getting ovarian cancer (150-400
out of 1000) who have a BRCA1 or BRCA2 mutation. In turn, several factors have been associated with a decreased risk
of ovarian cancer such as the use of oral contraceptives for 5 or more years, multiple pregnancies or having a full-term
pregnancy before the age of 25, having a hysterectomy or having fallopian tubes tied, or removal of the fallopian tubes
and ovaries. In women who have prophylactic removal of the fallopian tubes and ovaries, primary peritoneal cancer can
still occur but it is infrequent.
Approximately 85-90% of ovarian cancer is epithelial ovarian cancer and is believed to originate from a type of tissue
called the epithelium, which covers the ovary surface. The serous type of epithelial ovarian cancer is the most common;
mucinous, endometrioid and clear cell are three other types that each has distinct behaviors. There is no screening
method for early detection of ovarian cancer. The symptoms of the disease are vague, and not always gynecologic.
Research shows that women with ovarian cancer often report having the following symptoms: a swollen or bloated
abdomen, persistent pressure or pain in the abdomen or pelvis, difficulty eating or feeling full quickly, urinary urgency or
frequency, change in bowel habits with new onset constipation and/or diarrhea, and unexplained vaginal bleeding, If a
woman has some suspicion that she has the symptoms of ovarian cancer she should see her OB/GYN. If there is suspicion
she may have ovarian cancer based on early testing, she should seek a referral to a gynecologic oncologist. Studies have
shown that women with ovarian cancer treated by gynecological oncologists live longer than women treated by physicians
without this specialty training.
Dr. Alpa Nick
Research Grant Chair
Ovarcome Non-Profit Inc.
Assistant Professor, Department of Gynecologic Oncology and Reproductive Medicine, Division
of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
21. May 2015 21
It was my mother who explained to me that true
power lies in the intellect and spirit, not in the body.
We lived in a neighborhood in the Bronx that was so
gang-infested there was little room for peace-loving
folk. My Mom knew that if I was going to survive I
would have to use my wits, and she encouraged me
to do so.
In those days, a girl growing up in New York – or any
large city in America—could expect to be harassed
on the street as a matter of course. For this reason,
many of us chose the path of least resistance and tried
to remain invisible and avoid attracting attention.
Women’s liberation was a slogan at best – there were
no sexual discrimination laws on the books and we all
had to fend for ourselves.
Looking back, I am amazed to see how much has
changed.MostofthewomenImeettodayareconfident
in themselves and actively involved in making the
world a better place through organizations such as
Ovarcome. There is no doubt that the ‘weaker sex’ is
gone for good – we have found our strength.
So beyond working out in the gym and becoming
consummate arm wrestlers, what do we mean when
we talk about women power?
For me the answer lies not in definitions provided by
the exterior world, although I have nothing against
worldly success, but rather in following the inner
path. Through gaining self-knowledge from our
experiences and trusting our intuition, we find our
gifts and share them with others. And as women, we
have an advantage in pursuing our dreams. Yes we
do. Because nature has given us the courage to face
the pain of childbirth combined with an instinct to
nurture the creative spirit in ourselves and others.
Our ancestors were the first to grow and harvest
food. We started as gatherers… and have grown into
hunters as well.
There are still days when I feel powerless, unable to
stop the senseless violence and social injustice that
permeates our world. When that happens I look for
strength in my community of women who sing, write,
cook, sew, laugh, cry, build, incite, discuss, learn,
cultivate, experiment, and grow.
Our power is to inspire; our strength is to love.
THE POWER OF WOMEN
by Joyce Yarrow
22. May 2015 22
Comprehensive Compassionate Care for Women
17510West Grand Parkway South • Suite 550 • Sugar Land,TX 77479
Call 713.486.1250 for appointments
www.UTPhysicians.com
Brian R. Heaps, MD
Board Certified Ob/Gyn
Azeema Moosa, MD
Board Certified Ob/Gyn
MichelleWong, MD
Board Certified Ob/Gyn
23. May 2015 23
2015 Silent Auction Contributors:
Hotel Sorella, * Sweetwater Country Club, * Salima Merchant, * PRB Boutique, *Arbonne International,
* Sumana Dey, * Asma Rahim, *Accurate Watch, *AR Designs by Arefa Merchant, *Days Inn Alamo Riverwalk
Supporters & Contributors:
* Dr. Anil Sood, * Omprakash & Juuhi Ahuja, * Dr. Priya & Ranjit Bhosale, * Dr. Anirban Maitra,
* Dr. Karen Lu, *Dr. Ashish & Dr. Aparna Kamat, * Molly Daniels, * Dr. Lorenzo Cohen,
* Dr. Diane Bodurka,* Dr. Monica Roberson * Dr. Alpa & Jonathon Nick, * Mike & Beverly Beck,
* Rob & Lisa Heifner, * Craig & Betty White, * Dawn Scheirer, * Andrew Taktajian, * Jeff Borchers, * Scott Noel
* Joyce Yarrow * Sanjay Kanakia * Shilpa Chakroborty * Rice University, Jones Graduate School of Business,
* MD Anderson Cancer Center, * The Methodist Hospital, * Memorial Hermann, * CHI St. Luke’s Sugar Land, * Texas
Oncology, * UT Physicians Women’s Center Sugar Land, * Connexion Research, *Dr. Prajnan & Rakhee Das, * Rajesh &
Mita Ghosh, * Dr. Shona Nag, * Dr. Jaydip Bhaumik, Dr. Sudeep Gupta,* Rick & Tanya Pal, * Sweetwater Country Club,
* Hotel Sorella, * Tanaz & Chelsea Choudhury, * Zory Ernull
…And many others who have come forward at different intervals to support out cause. We are grateful to our
supporters and sincerely apologize for any inadvertent omissions. List as of 05/1/2015 to allow for printing.
2015 Gala Event Hosts: Melinda Spaulding & Lisa Slater
Publicity: Culture Map, Fort Bend Focus, Indo-American News, FOX 26 Houston, ABC -13 News,
Jones Business Journal, Lights Camera Action (Ruchi Mukherjee)
Photography: Rgueta Photography
Creative Graphics & Content Designs: Srikanth Alugoju, Wise Men
Music Performance: Ms. Pamela Mary & Chloe Choudhury
2015 Gala Event Committee: Bhavana Bajaj, Asma Rahim, Karen Francis
Our heartfelt thanks to the following people for their address to Ovarcome supporters:
Dr. Ronald DePinho, President, MD Anderson Cancer Center
Dr. Robert C. Bast, Jr., VP for Translational Research, MD Anderson Cancer Center
Mike Beck, Chief Sales Officer & Head of Marketing, Direct Energy
2015 Survivor Ovar The Moon Walk Sponsors:
Ovations Hair Studio & Spa: hair & make-up by Pedro Abasolo
Kendra Scott: jewelry by Allie Nicholson
Auggie Apparel: apparel provided by Brian & Blake
Accurate Watch: 22K gold plated watches provided by Asma Rahim & her Dad
Sincere And Heartfelt Thanks
To Ovarcome Friends For Their Continued Support
24. May 2015 24
Ovarcome Governing Board:
*Runsi Sen: Founder and President, Dr. Priya
Bhosale, International Operations Chair, *Dr.
Alpa Nick, Research Grant Chair, * Jeff Borchers,
Treasurer, * Mike Beck, * Rob Heifner, * Juuhi Ahuja,
* Dawn Scheirer, * Dr. Aparna Kamat, * Andrew
Taktajian, * Betty White
Ovarcome Advisory Board:
Dr. Anil Sood * Dr. Anirban Maitra* Dr. Subrata Ghosh*
Dr. Kathleen Schmeler* Dr. Monica Roberson * Dr.
Jaydip Bhaumik * Dr. Shona Nag
Ovarcome India Chapter Chairs:
Sanjay Kanakia (West Coast)
Shilpa Chakroborty (East Coast)
Ovarcome USA Team:
*Bhavana Bajaj, * Israel Isassi, * Danelia Argueta,
* Justine steele, * Raul Luzarraga
Ovarcome Africa Chair:
Scott Noel
Ovarcome Gala 2015 Chairs:
Karen Francis * Bhavana Bajaj * Asma Rahim
3015 Richmond Avenue,
Suite 120-C, Houston, TX 77098
Website: www.ovarcome.org
Email: info@ovarcome.org
